Filing Details

Accession Number:
0001387131-19-007990
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 17:03:15
Reporting Period:
2019-10-25
Accepted Time:
2019-10-29 17:03:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532230 Iv C.k. John Milligan 951 Yamato Road
Suite 220
Boca Raton FL 33431
President/Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-25 72,000 $2.75 1,544,419 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,582,373 Indirect See Footnote
Common Stock 434,814 Indirect See Footnote
Footnotes
  1. Represents a purchase from the underwriters in the issuer's public offering.
  2. Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
  3. Shares are owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.